Mast-cell growth and differentiationLI, L; KRILIS, S. A.Allergy (Copenhagen). 1999, Vol 54, Num 4, pp 306-312, issn 0105-4538Article

Heterogeneity of lupus anticoagulant (LA) antibodies : LA activity in dilute Russell's Viper Venom time and dilute Kaolin cloning time detect different populations of antibodies in patients with the antiphospholipid syndromeKANDIAH, D. A; KRILIS, S. A.Thrombosis and haemostasis. 1998, Vol 80, Num 2, pp 250-257, issn 0340-6245Article

Cloning and characterization of the gene encoding the mouse β₂-Glycoprotein ISHENG, Y; HERZOG, H; KRILIS, S. A et al.Genomics (San Diego, Calif.). 1997, Vol 41, Num 1, pp 128-130, issn 0888-7543Article

New basis aspects of the antiphospholipid syndromeHUNT, J. E; ADELSTEIN, S; KRILIS, S. A et al.Clinical and experimental rheumatology (Testo stampato). 1994, Vol 12, Num 6, pp 661-668, issn 0392-856XArticle

Antiphospholipid antibodiesMCNEIL, H. P; KRILIS, S. A.Australian and New Zealand journal of medicine. 1991, Vol 21, Num 4, pp 463-475, issn 0004-8291, 11 p.Article

Binding specificity of lupus anticoagulants and anticardiolipin antibodiesMCNEIL, H. P; CHESTERMAN, C. N; KRILIS, S. A et al.Thrombosis research. 1988, Vol 52, Num 6, pp 609-619, issn 0049-3848Article

Risk stratificatiion and outcome of cellulitis admitted to hospitalFIGTREE, M; KONECNY, P; JENNINGS, Z et al.The Journal of infection. 2010, Vol 60, Num 6, pp 431-439, issn 0163-4453, 9 p.Article

Conditioned media obtained from a human mastocytosis cell strain induce mast cells expressing chymase but not tryptase from human progenitorsLI, L; KRILIS, S. A.International archives of allergy and immunology. 1997, Vol 113, Num 1-3, pp 289-290, issn 1018-2438Conference Paper

Antiphospholipid antibodies : new insights into their specificity and clinical importanceMCNEIL, H. P; HUNT, J. E; KRILIS, S. A et al.Scandinavian journal of immunology (Print). 1992, Vol 36, Num 5, pp 647-652, issn 0300-9475Article

Sneddon's syndrome, anti-cardiolipin antibody and glomerular thrombosisSTEVENS, J. M; HUNT, J. E; SEYMOUR, A. E et al.Clinical nephrology. 1994, Vol 41, Num 1, pp 18-22, issn 0301-0430Article

Production and characterization of antibodies to platelet-activating factorMACPHERSON, J. L; SPUR, B; PYNE, S. G et al.Journal of lipid mediators. 1992, Vol 5, Num 1, pp 49-59, issn 0921-8319Article

Patients with anticardiolipin antibodies with and without antiphospholipid syndrome : their clinical features and β₂-glycoprotein-I plasma levelsVLACHOYIANNOPOULOS, P. G; KRILIS, S. A; HUNT, J. E et al.European journal of clinical investigation. 1992, Vol 22, Num 7, pp 482-487, issn 0014-2972Article

Substrate for endothelial prostacyclin production in the presence of platelets exposed to collagen is derived from the platelets rather than the endotheliumCHESTERMAN, C. N; OWE-YOUNG, R; MACPHERSON, J et al.Blood. 1986, Vol 67, Num 6, pp 1744-1750, issn 0006-4971Article

Small bowel mucosa from celiac patients generates 15-hydroxyeicosatetraenoic acid (15-hete) after in vivo challenge with glutenKRILIS, S. A; MACPHERSON, J. L; DE CARLE, D. J et al.The Journal of immunology (1950). 1986, Vol 137, Num 12, pp 3768-3771, issn 0022-1767Article

Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy populationSHI, W; KRILIS, S. A; CHONG, B. H et al.Australian and New Zealand journal of medicine. 1990, Vol 20, Num 3, pp 231-236, issn 0004-8291Article

Identification of a region of β₂-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activityHUNT, J. E; SIMPSON, R. J; KRILIS, S. A et al.Proceedings of the National Academy of Sciences of the United States of America. 1993, Vol 90, Num 6, pp 2141-2145, issn 0027-8424Article

Immunology and clinical importance of antiphospholipid antibodiesMCNEIL, H. P; CHESTERMAN, C. N; KRILIS, S. A et al.Advances in immunology. 1991, Vol 49, pp 193-280, issn 0065-2776, 88 p.Article

Purification of antiphospholipid antibodies using a new affinity methodMCNEIL, H. P; KRILIS, S. A; CHESTERMAN, C. N et al.Thrombosis research. 1988, Vol 52, Num 6, pp 641-648, issn 0049-3848Article

In vivo modulation of angiogenesis by beta 2 glycoprotein IPASSAM, F. H; QI, J. C; TANAKA, K et al.Journal of autoimmunity (Print). 2010, Vol 35, Num 3, pp 232-240, issn 0896-8411, 9 p.Article

Pathogenic role of anti-β2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of β2-glycoprotein I binding to trophoblast cells and functional effects of anti-β2-glycoprotein I antibodies in vitroDI SIMONE, N; RASCHI, E; TESTONI, C et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 3, pp 462-467, issn 0003-4967, 6 p.Article

Association of mast cells with fibrosis and fatty infiltration in the minor salivary glands of patients with Sjögren's syndromeSKOPOULI, F. N; LI, L; BOUMBA, D et al.Clinical and experimental rheumatology (Testo stampato). 1998, Vol 16, Num 1, pp 63-65, issn 0392-856XArticle

Co-culture of human bone marrow cells with a mastocytosis cell strain induces mast cell/basophil differentiationMACPHERSON, J. L; LOPEZ, A; KRILIS, S. A et al.International archives of allergy and immunology. 1992, Vol 99, Num 2-4, pp 346-349, issn 1018-2438Conference Paper

Establishment in culture and characterization of a strain with mast cell and monocytic properties from the bone marrow of a child diffuse cutaneous mastocytosisKRILIS, S. A; WARNEFORD, S. G; MACPHERSON, J et al.Blood. 1991, Vol 78, Num 2, pp 290-303, issn 0006-4971Article

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation : β₂-glycoprotein I (apolipoprotein H)MCNEIL, H. P; SIMPSON, R. J; CHESTERMAN, C. N et al.Proceedings of the National Academy of Sciences of the United States of America. 1990, Vol 87, Num 11, pp 4120-4124, issn 0027-8424, 5 p.Article

Distinguishing features of Anti-β₂ glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndromeARVIEUX, J; RENAUDINEAU, Y; MANE, I et al.Thrombosis and haemostasis. 2002, Vol 87, Num 4, pp 599-605, issn 0340-6245Article